CHUK and neoplasm: Here, we further studied the in vivo effect of WCE on a CRPC model and demonstrated that among the three active components, wedelolactone simultaneously suppresses IKKα/β signaling in cancer cells and modulates the activity of tumor-induced myeloid cells.